PRME
Price:
$2.739
Market Cap:
$359.25M
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2022-10-20
Stock Exchange
NASDAQ
Ticker
PRME
According to Prime Medicine, Inc.’s latest financial reports and current stock price. The company's current ROE is -114.95%. This represents a change of 270.93% compared to the average of -30.99% of the last 4 quarters.
The mean historical ROE of Prime Medicine, Inc. over the last ten years is -73.74%. The current -114.95% ROE has changed 55.89% with respect to the historical average. Over the past ten years (40 quarters), PRME's ROE was at its highest in in the December 2022 quarter at 13.38%. The ROE was at its lowest in in the March 2021 quarter at -258.89%.
Average
-73.74%
Median
-69.03%
Minimum
-182.07%
Maximum
41.49%
Discovering the peaks and valleys of Prime Medicine, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 577.62%
Maximum Annual ROE = 41.49%
Minimum Annual Increase = -458.82%
Minimum Annual ROE = -182.07%
Year | ROE | Change |
---|---|---|
2023 | -148.89% | -458.82% |
2022 | 41.49% | -160.11% |
2021 | -69.03% | 577.62% |
2020 | -10.19% | -94.40% |
The current ROE of Prime Medicine, Inc. (PRME) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-58.81%
5-year avg
-73.74%
10-year avg
-73.74%
Prime Medicine, Inc.’s ROE is greater than Beam Therapeutics Inc. (-16.22%), greater than Caribou Biosciences, Inc. (-45.46%), greater than Intellia Therapeutics, Inc. (-51.97%), greater than Sana Biotechnology, Inc. (-94.47%), greater than Reneo Pharmaceuticals, Inc. (-62.53%), greater than Ginkgo Bioworks Holdings, Inc. (-70.11%), less than Ocean Biomedical, Inc. (75.64%), less than Royalty Pharma plc (17.37%), greater than Editas Medicine, Inc. (-80.13%), greater than CRISPR Therapeutics AG (-12.15%), greater than Verve Therapeutics, Inc. (-35.23%), greater than Theseus Pharmaceuticals, Inc. (-12.35%), greater than aTyr Pharma, Inc. (-56.83%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Century Therapeutics, Inc. (-66.58%), greater than Blueprint Medicines Corporation (-47.66%),
Company | ROE | Market cap |
---|---|---|
-16.22% | $2.40B | |
-45.46% | $150.77M | |
-51.97% | $1.24B | |
-94.47% | $385.14M | |
-62.53% | $60.84M | |
-70.11% | $526.79M | |
75.64% | $20.89M | |
17.37% | $11.17B | |
-80.13% | $101.12M | |
-12.15% | $3.48B | |
-35.23% | $490.80M | |
-12.35% | $181.50M | |
-56.83% | $131.12M | |
-45.75% | $703.85M | |
-66.58% | $86.73M | |
-47.66% | $5.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prime Medicine, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prime Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Prime Medicine, Inc.'s ROE?
How is the ROE calculated for Prime Medicine, Inc. (PRME)?
What is the highest ROE for Prime Medicine, Inc. (PRME)?
What is the 3-year average ROE for Prime Medicine, Inc. (PRME)?
What is the 5-year average ROE for Prime Medicine, Inc. (PRME)?
How does the current ROE for Prime Medicine, Inc. (PRME) compare to its historical average?